| | Patient | Age/sex | Etiology | Other AEDs | Order of IV LCM | Loading/maintenance dose (MKDose) | % seizure reduction in 24 hr | Efficacy (% seizure reduction) | Side effect |
| | 1 | 10 Y | Traumatic brain injury | LEV, CZP, VPA, TPM | 3 | 10/6.6 | 85.71 | No change | No | | 2 | 12 M | Lennox-Gastaut syndrome | LEV, DZP, CLB, TPM, PPN | 2 | 10/5 | 75 | >50% | bradycardia | | 3 | 15 Y | Anti NMDAR encephalitis | LEV, TPM | 1 | 6.7/2.2 | 100 | Seizure free | No | | 4 | 9 M | neuronal ceroid lipofusinosis | LEV, CZP, VPA, TPM, LTG | 3 | 8/5 | 85 | >50% | No | | 5 | 9 Y | focal epilepsy of unknown etiology | LEV, PHT | 4 | 4.7/4.7 | 100 | No change | No | | 6 | 14 Y | focal epilepsy of unknown etiology | LEV, VPA, TPM | 3 | 5/2.5 | 100 | >50% | No | | 7 | 14 Y | Lennox-Gastaut syndrome | LEV, TPM, CLB, PB | 2 | 9/4.5 | 90 | >75% | No | | 8 | 10 Y | focal epilepsy of unknown etiology | VPA, TPM, CBZ | 2 | 9/4.5 | 100 | >75% | No | | 9 | 7 Y | Schizencephaly | TPM, DZP, PB | 3 | 10/5 | 66.67 | >75% | No | | 10 | 16 Y | focal epilepsy of unknown etiology | PHT, TPM, CZP | 2 | 10/5 | 100 | No change | No | | 11 | 8 M | Lennox-Gastaut syndrome | LEV, PPN, LTG, PB | 2 | 8.7/5.2 | 71.42 | >75% | No |
|
|
